5-272766-T-A

Position:

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4

The NM_013232.4(PDCD6):​c.157T>A​(p.Ser53Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 27)

Consequence

PDCD6
NM_013232.4 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.18
Variant links:
Genes affected
PDCD6 (HGNC:8765): (programmed cell death 6) This gene encodes a calcium-binding protein belonging to the penta-EF-hand protein family. Calcium binding is important for homodimerization and for conformational changes required for binding to other protein partners. This gene product participates in T cell receptor-, Fas-, and glucocorticoid-induced programmed cell death. In mice deficient for this gene product, however, apoptosis was not blocked suggesting this gene product is functionally redundant. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is also located on the short arm of chromosome 5. [provided by RefSeq, May 2012]
PDCD6-AHRR (HGNC:54724): (PDCD6-AHRR readthrough (NMD candidate)) Predicted to enable calcium ion binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM1
In a mutagenesis_site Slightly reduced interaction with SEC31A. Does not affect interaction with PDCD6IP. (size 0) in uniprot entity PDCD6_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.37851706).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PDCD6NM_013232.4 linkuse as main transcriptc.157T>A p.Ser53Thr missense_variant 2/6 ENST00000264933.9 NP_037364.1 O75340-1Q53FC3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PDCD6ENST00000264933.9 linkuse as main transcriptc.157T>A p.Ser53Thr missense_variant 2/61 NM_013232.4 ENSP00000264933.4 O75340-1
ENSG00000286001ENST00000651543.1 linkuse as main transcriptn.*1527T>A non_coding_transcript_exon_variant 19/24 ENSP00000499215.1 A0A494C1T6
PDCD6-AHRRENST00000675395.1 linkuse as main transcriptn.157T>A non_coding_transcript_exon_variant 2/14 ENSP00000502570.1 A0A6Q8PH81
ENSG00000286001ENST00000651543.1 linkuse as main transcriptn.*1527T>A 3_prime_UTR_variant 19/24 ENSP00000499215.1 A0A494C1T6

Frequencies

GnomAD3 genomes
Cov.:
27
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
27

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 24, 2024The c.157T>A (p.S53T) alteration is located in exon 2 (coding exon 2) of the PDCD6 gene. This alteration results from a T to A substitution at nucleotide position 157, causing the serine (S) at amino acid position 53 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.82
BayesDel_addAF
Uncertain
0.021
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Benign
0.83
DEOGEN2
Uncertain
0.47
T;T;.;T;.;.
Eigen
Benign
-0.047
Eigen_PC
Benign
-0.020
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.38
T;T;T;T;T;T
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Benign
2.0
M;.;M;.;M;.
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-2.4
N;.;D;D;N;N
REVEL
Benign
0.15
Sift
Benign
0.36
T;.;T;D;T;T
Sift4G
Benign
0.44
T;T;T;T;T;T
Polyphen
0.0010
B;.;.;.;.;.
Vest4
0.54
MutPred
0.49
Gain of catalytic residue at S53 (P = 0.121);Gain of catalytic residue at S53 (P = 0.121);Gain of catalytic residue at S53 (P = 0.121);Gain of catalytic residue at S53 (P = 0.121);Gain of catalytic residue at S53 (P = 0.121);.;
MVP
0.90
MPC
2.3
ClinPred
0.32
T
GERP RS
4.3
Varity_R
0.53
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-272881; API